Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01585480 · ClinicalTrials.gov registry record · NA
Preventing Obesity in the Worksite: A Multi-Message, Multi-"Step" Approach
A NA study, sponsored by University of Minnesota.
- Completed
- Registry status
- NA
- Development phase
- 499
- Enrollment target
NCT01585480: Completed NA study, sponsored by University of Minnesota.
NCT01585480 is a NA study that has completed, run by University of Minnesota. The registered enrollment target is 499 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (64% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01585480, a NA study, has completed, sponsored by University of Minnesota.
- COMPLETED
- Registry status
- NA
- Development phase
- 499 participants
- Enrollment target
Study Summary
The purpose of this research study is to develop, implement, and evaluate a multi-component obesity prevention program in a workplace setting. A quasi-experimental design will be utilized, with hospital employees receiving the intervention and clinic employees serving as the comparison group. It is hypothesized that the intervention group will see greater changes in healthier eating, increased participation in physical activity, and reduced risk for obesity (weight, BMI, waist circumference).
Interventions
- BEHAVIORAL Weight Gain Prevention Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 499 participants |
| Start Date | 2010-11 |
| Est. Completion | 2011-12 |
| Phase | NA |
What the finished NCT01585480 record still lists
NCT01585480 is an interventional study that assigns participants to a tested intervention. The registered 499 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (64% lower).
The record links to 0 conditions, and to 1 intervention - of which Weight Gain Prevention Intervention is the first listed.
NCT01585480 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01585480 about?
NCT01585480 is a clinical study titled "Preventing Obesity in the Worksite: A Multi-Message, Multi-"Step" Approach". The purpose of this research study is to develop, implement, and evaluate a multi-component obesity prevention program in a workplace setting. A quasi-experimental design will be utilized, with hospital employees receiving the intervention and clinic employees serving as the comparison group. It is ...
What is the current status of trial NCT01585480?
This trial is currently completed. It is a NA study. The enrollment target is 499 participants. The study started on 2010-11. Estimated completion is 2011-12.
What interventions are being tested in trial NCT01585480?
The interventions under investigation include: Weight Gain Prevention Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT01585480?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01585480's enrollment target sits among peer trials
499 213th of 2000 higher than 1,788 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04137900 · 499 participants · Phase 1
Safety, Tolerability and Pharmacokinetics of a Monoclonal Antibody Specific to B-and T-Lymphocyte Attenuator (BTLA) as Monotherapy and in Combination With an Anti-PD1 Monoclonal Antibody for Injection in Subjects With Advanced Malignancies
- NCT06733480 · 499 participants · NA
Innovating Physical Therapy: A Pilot Study on Band Connect's Impact on Compliance, Satisfaction, and Revenue
- NCT00001230 · 500 participants
Host Response to Infection and Treatment in Filarial Diseases
- NCT00001529 · 500 participants
Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia